A PASE Approach towards (Adamantyl-1)-, Alkyl- and (Het)Aryl-Substituted [1, 2,4]triazolo[1, 5-d][1, 2,4]triazines: A Sequence of Two Solvent-Free Reactions Bearing Lower E-Factors

[1]  O. Chupakhin,et al.  Substitution of Cyano Group in Position 5 of 1,2,4-Triazines by Carboxylic Acid Hydrazide Residues under Solvent-Free Conditions , 2018, Russian Journal of Organic Chemistry.

[2]  G. Zyryanov,et al.  Pot, Atom, Step Economic (PASE) Approach towards (Aza)‐2,2′‐Bipyridines: Synthesis and Photophysical Studies , 2018 .

[3]  E. Kool,et al.  Fluorescent nucleobases as tools for studying DNA and RNA. , 2017, Nature chemistry.

[4]  G. Zyryanov,et al.  Brønsted acidic ionic liquid-catalyzed tandem reaction: an efficient approach towards regioselective synthesis of pyrano[3,2-c]coumarins under solvent-free conditions bearing lower E-factors , 2017 .

[5]  G. Zyryanov,et al.  Solvent-free synthesis of 5-(aryl/alkyl)amino-1,2,4-triazines and α-arylamino-2,2′-bipyridines with greener prospects , 2017 .

[6]  M. M. Heravi,et al.  Synthesis of bis[1,2,4]triazolo[4,3-b:1′,5′-d][1,2,4]triazine, a novel polynitrogenated heterocyclic system , 2017, Monatshefte für Chemie - Chemical Monthly.

[7]  G. Zyryanov,et al.  3-Cyano-2-azaanthracene-based “push-pull” fluorophores: A one-step preparation from 5-cyano-1,2,4-triazines and 2,3-dehydronaphthalene, generated in situ , 2016 .

[8]  O. Chupakhin,et al.  Potassium salt of nitroacetonitrile in the synthesis of nitrogen heterocycles , 2015, Chemistry of Heterocyclic Compounds.

[9]  J. Antosiewicz,et al.  8-Azapurines as isosteric purine fluorescent probes for nucleic acid and enzymatic research. , 2014, Molecular bioSystems.

[10]  C. Kaiser,et al.  Syntheses and antimycobacterial activities of [(2S,3R)-2-(amino)-4-(arenesulfonamido)-3-hydroxy-1-phenylbutane derivatives. , 2014, Medicinal chemistry (Shariqah (United Arab Emirates)).

[11]  M. Kukhanova,et al.  Synthesis of acyclic nucleoside analogues based on 1,2,4-triazolo[1,5-a]pyrimidin-7-ones by one-step Vorbrüggen glycosylation , 2014 .

[12]  T. Nagamatsu,et al.  Synthesis of 6-Azapurines by Transformation of Toxoflavins and Reumycins (7-Azapteridines) and their Cytotoxicities , 2014 .

[13]  S. Santra,et al.  Copper‐Catalyzed Synthesis of Imidazo[1,2‐a]pyridines through Tandem Imine Formation‐Oxidative Cyclization under Ambient Air: One‐Step Synthesis of Zolimidine on a Gram‐Scale , 2013 .

[14]  P. Schreiner,et al.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives. , 2013, Chemical reviews.

[15]  S. Santra,et al.  Iron(III)-Catalyzed Cascade Reaction between Nitroolefins and 2-Aminopyridines: Synthesis of Imidazo[1,2-a]pyridines and Easy Access towards Zolimidine , 2013 .

[16]  R. Lamb,et al.  Inhibitors of the Influenza A Virus M2 Proton Channel Discovered Using a High-Throughput Yeast Growth Restoration Assay , 2013, PloS one.

[17]  A. Arseniev,et al.  Synthesis of the [2H,15N]-labeled antiviral drug “triazavirine” , 2011 .

[18]  Graciela Artavia,et al.  Use of the adamantane structure in medicinal chemistry. , 2010, Current medicinal chemistry.

[19]  M. Kukhanova,et al.  Antiviral Properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B Virus Replication , 2010, Antimicrobial Agents and Chemotherapy.

[20]  W. Parker.  Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. , 2009, Chemical reviews.

[21]  Xianghong Jing,et al.  Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel , 2008, Proceedings of the National Academy of Sciences.

[22]  O. Chupakhin,et al.  Azolo[5,1-c]-1,2,4-triazines as a new class of antiviral compounds , 2008 .

[23]  A. V. Koksharov,et al.  A novel approach to fused 1,2,4-triazines by intramolecular cyclization of 1,2-diaza-1,3-butadienes bearing allyl(propargyl)sulfanyl and cyclic tert-amino groups , 2007 .

[24]  Roger A. Sheldon,et al.  The E Factor: fifteen years on , 2007 .

[25]  O. Chupakhin,et al.  Carborane-Functionalized Polyaza Aromatic Ligands: Synthesis, Crystal Structure, and a Copper(II) Complex , 2006 .

[26]  B. Vojtesek,et al.  8-Azapurines as new inhibitors of cyclin-dependent kinases. , 2005, Bioorganic & medicinal chemistry.

[27]  O. V. Shabunina,et al.  From 3-chloromethyl-1,2,4-triazine 4-oxides to various substituted pyridines and 1,2,4-triazines , 2005 .

[28]  M. Rahimizadeh,et al.  Synthesis of 1,2,4-triazolo[1,5-d]-1,2,4-triazine-5-thiones , 2005 .

[29]  R. Webster,et al.  Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells , 2004, Antimicrobial Agents and Chemotherapy.

[30]  O. Chupakhin,et al.  Synthesis of 8-Aryl[1,2,4]triazolo[1,5-d][1,2,4]triazin-5(6H)-ones by S HN Reactions , 2004 .

[31]  O. Chupakhin,et al.  Transformations of 1,2,4-Triazines in Reactions with Nucleophiles: V. SNH and ipso-Substitution in the Synthesis and Transformations of 5-Cyano-1,2,4-triazines , 2002 .

[32]  T. V. Nikitina,et al.  Synthesis of functionalised bipyridines by sequential nucleophilic substitution of hydrogen and cycloaddition in 1,2,4-triazine rings , 2002 .

[33]  E. N. Ulomsky,et al.  Nucleophilic substitution of hydrogen in the reaction of 1,2,4-triazine-4-oxides with cyanides , 1997 .

[34]  M. Mąkosza,et al.  Reactions of 1,2,4-triazines with nitromethide ion. A convenient method of preparation of 1,2,4-triazin-5-ylcarbaldehyde oximes and their synthetic applications† , 1996 .

[35]  Jim J. Huang.  Synthesis of fused 1,2,4-triazines: 6- and 7-azapteridine and 6-azapurine ring systems , 1985 .

[36]  R. Subramanian,et al.  Tromantadine: inhibitor of early and late events in herpes simplex virus replication , 1982, Antimicrobial Agents and Chemotherapy.

[37]  K. Geagan,et al.  [1,2,4]Triazines. 4. Regiospecific ring closure reactions involving 6-amino-5-hydrazino[1,2,4]triazin-3(2H)-ones and orthoesters , 1982 .

[38]  M. Legraverend,et al.  Synthese de s-triazolo[4,3-d] et [1,5-d] triazines-1,2,4 , 1981 .

[39]  D. Kau,et al.  The adamantyl group in medicinal agents. 3. Nucleoside 5'-adamantoates. The adamantoyl function as a protecting group. , 1967, Journal of medicinal chemistry.